Influence of Age and Histology on Outcome in Adult Non-Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT): A Report from The Center For International Blood & Marrow Transplant Research (CIBMTR)

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 12, 2008, Pages 1323-1333

  Lazarus, Hillard M ^a   Carreras, Jeanette ^b   Boudreau, Christian ^c   Loberiza Jr , Fausto R ^d   Armitage, James O ^d   Bolwell, Brian J ^e   Freytes, César O ^f   Gale, Robert Peter ^g   Gibson, John ^h   Hale, Gregory A ⁱ   Inwards, David J ^j   LeMaistre, Charles F ^k   Maharaj, Dipnarine ^l   Marks, David I ^m   Miller, Alan M ⁿ   Pavlovsky, Santiago ^o   Schouten, Harry C ^p   van Besien, Koen ^q   Vose, Julie M ^d   Bitran, Jacob D ^r   Khouri, Issa F ^s   McCarthy, Philip L ^t   Yu, Hongmei ^u   Rowlings, Philip ^v   Serna, Derek S ^b   Horowitz, Mary M ^b   Rizzo, J Douglas ^b   more..

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF WATERLOO   (Canada)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g Center for Advanced Studies in Leukemia   (United States)

^h ROYAL PRINCE ALFRED HOSPITAL   (Australia)

ⁱ St Jude Children's Research Institute   (United States)

^j MAYO CLINIC   (United States)

^k TEXAS TRANSPLANT INSTITUTE   (United States)

^l South Florida Bone Marrow Stem Cell Transplant Institute   (United States)

^m BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

ⁿ TULANE UNIVERSITY MEDICAL CENTER   (United States)

^o Fundacion para Combatir La Leucemia   (Argentina)

^p MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^q UNIVERSITY OF CHICAGO   (United States)

^r ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

^s UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^t ROSWELL PARK CANCER INSTITUTE   (United States)

^u SHANXI MEDICAL UNIVERSITY   (China)

^v NEWCASTLE MATER HOSPITAL   (Australia)

more..

Author keywords

Autologous HCT; Elderly; Non Hodgkin lymphoma; Relapse; Second complete remission

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER GRADING; CANCER MORTALITY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; ELDERLY CARE; FEMALE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGE FACTORS; AGED; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS;

EID: 56749184062     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.09.008     Document Type: Article

References (37)

1. O'Reilly S.E., Connors J.M., Macpherson N., et al. Malignant lymphomas in the elderly. Clin Geriatr Med 13 (1997) 251-263
2. Devesa S.S., and Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 52 (1992) 5432s-5440s
3. Shipp M.A., Anderson J.R., et al. A predictive model for aggressive non-Hodgkin's lymphoma. The Internationl Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med (1993) 987-994
4. Solal-Celigny P., Roy P., Colombat P., et al. Follicular lymphoma international prognostic index. Blood 104 (2004) 1258-1265
5. Miller C.B., Piantadosi S., Vogelsang G.B., et al. Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant. J Clin Oncol 14 (1996) 1327-1332
6. Kusnierz-Glaz C.R., Schlegel P.G., Wong R.M., et al. Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies. J Clin Oncol 15 (1997) 18-25
7. Weaver C.H., Schwartzberg L.S., Hainsworth J., et al. Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers. Bone Marrow Transplant 19 (1997) 671-678
8. Freedman A.S., Neuberg D., Mauch P., et al. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. Blood 94 (1999) 3325-3333
9. Philip T., Guglielmi C., Hagenbeek A., et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333 (1995) 1540-1545
10. Krishnan A., Bhatia S., Slovak M.L., et al. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood 95 (2000) 1588-1593
11. Stiff P.J., Dahlberg S., Forman S.J., et al. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens-a Southwest Oncology Group trial. J Clin Oncol 16 (1998) 48-55
12. Bierman P.J., Vose J.M., Anderson J.R., et al. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol 15 (1997) 445-450
13. National Hospital Discharge Survey for 1990 and 1991. Hyattsville, MD: U.S. Department of Health and Human Services PHS, Centers for Disease Control, National Center for Health Statistics, Hospital Care Statistics Branch.
14. Graves E. Detailed diagnoses and procedures. National Hospital Discharge Survey, 1989 (1991), U.S. Department of Health and Human Services PHS, Hyattsville, MD
15. Curtis R.E., Rowlings P.A., Deeg H.J., et al. Solid cancers after bone marrow transplantation. N Engl J Med 336 (1997) 897-904
16. Silberman G., Crosse M.G., Peterson E.A., et al. Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries. N Engl J Med 331 (1994) 1063-1067
17. Kaplan E.L., and Meier P. Nonparametric estimation from in complete observations. J Am Stat Assoc 53 (1958) 457-481
18. Contal C., and O'Quigley J. An application of change point methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal 30 (1999) 253-270
19. Cox D.R. Regression models and life tables. J R Stat Soc B 34 (1972) 187-220
20. Therneau T.M., and Grambsch P.M. Modeling survival data: extending the Cox model (2000), Springer-Verlag, New York
21. Andersen P.K., Klein J.P., and Zhang M.J. Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Stat Med 18 (1999) 1489-1500
22. Sweetenham J.W., Pearce R., Philip T., et al. High-dose therapy and autologous bone marrow transplantation for intermediate and high grade non-Hodgkin's lymphoma in patients aged 55 years and over: results from the European Group for Bone Marrow Transplantation. The EBMT Lymphoma Working Party. Bone Marrow Transplant 14 (1994) 981-987
23. Stamatoullas A., Fruchart C., Khalfallah S., et al. Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age. Bone Marrow Transplant 19 (1997) 31-35
24. Moreau P., Milpied N., Voillat L., et al. Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study. Bone Marrow Transplant 21 (1998) 1193-1196
25. Mazza P., Palazzo G., Amurri B., et al. Analysis of feasibility of myeloablative therapy and autologous peripheral stem cell (PBSC) transplantation in the elderly: an interim report. Bone Marrow Transplant 23 (1999) 1273-1278
26. Jantunen E., Mahlamaki E., and Nousiainen T. Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (≥60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol. Bone Marrow Transplant 26 (2000) 737-741
27. Gopal A.K., Gooley T.A., Golden J.B., et al. Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older. Bone Marrow Transplant 27 (2001) 593-599
28. Bitran J.D., Klein L., Link D., et al. High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphoma. Biol Blood Marrow Transplant 9 (2003) 383-388
29. Leger C.S., Bredeson C., Kearns B., et al. Autologous blood and marrow transplantation in patients 60 years and older. Biol Blood Marrow Transplant 6 (2000) 204-210
30. Vose J.M., Rizzo D.J., Tao-Wu J., et al. Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. Biol Blood Marrow Transplant 10 (2004) 116-127
31. Schmitz N., Linch D.C., Dreger P., et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347 (1996) 353-357
32. Buadi F.K., Micallef I.N., Ansell S.M., et al. Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma. Bone Marrow Transplant 37 (2006) 1017-1022
33. Wildes T.M., Augustin K.M., Sempek D., et al. Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma. Biol Blood Marrow Transplant 14 (2008) 840-846
34. Hosing C., Saliba R.M., Okoroji G.J., et al. High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age. Ann Oncol 19 (2008) 1166-1171
35. Radich J.P., Gooley T., Bensinger W., et al. HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen. Blood 102 (2003) 31-35
36. Press O.W., Eary J.F., Gooley T., et al. A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas. Blood 96 (2000) 2934-2942
37. Gopal A.K., Rajendran J.G., Petersdorf S.H., et al. High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma. Blood 99 (2000) 3158-3162